Lumosa Therapeutics Co (ROCO:6535) Change In Inventory: NT$-5.48 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6535 Lumosa Therapeutics Co Ltd ROCO:6535
65 GF Score
Price NT$77.40
GF Value NT$138.12
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lumosa Therapeutics Co Change In Inventory?

Lumosa Therapeutics Co ROCO:6535 -4.33% 65 Change In Inventory is NT$-5.48 Mil as of Jun. 2026. GuruFocus rates ROCO:6535 with a GF Score™ of 65/100 and a GF Value™ of NT$138.12 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Lumosa Therapeutics Co's change in inventory for the quarter that ended in Jun. 2026 was NT$-5.77 Mil. It means Lumosa Therapeutics Co's inventory increased by NT$5.77 Mil from Mar. 2026 to Jun. 2026 .

Lumosa Therapeutics Co's change in inventory for the fiscal year that ended in Dec. 2025 was NT$-1.00 Mil. It means Lumosa Therapeutics Co's inventory increased by NT$1.00 Mil from Dec. 2024 to Dec. 2025 .

Lumosa Therapeutics Co's Total Inventories for the quarter that ended in Jun. 2026 was NT$102.11 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Lumosa Therapeutics Co's Days Inventory for the quarter that ended in Jun. 2026 was 2,578.81.

Inventory Turnover measures how fast the company turns over its inventory within a year. Lumosa Therapeutics Co's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.04.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lumosa Therapeutics Co's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 19.35.

Lumosa Therapeutics Co  (ROCO:6535) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lumosa Therapeutics Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=99.224/3.511*365 / 4
=2,578.81

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lumosa Therapeutics Co's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=3.511 / 99.224
=0.04

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lumosa Therapeutics Co's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=99.224 / 5.129
=19.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumosa Therapeutics Co Change In Inventory Related Terms

Lumosa Therapeutics Co Change In Inventory Historical Data

* Premium members only.

The historical data trend for Lumosa Therapeutics Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumosa Therapeutics Co Change In Inventory Chart

Lumosa Therapeutics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -50.61 -26.30 4.77 6.13 -1.00

Lumosa Therapeutics Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 1.41 -3.56 2.44 -5.77
ROCO:6535
65GF Score
Lumosa Therapeutics Co Ltd ROCO:6535
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lumosa Therapeutics Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-5.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of NT$-5.48 Mil mean?
Lumosa Therapeutics Co (ROCO:6535) has a Change In Inventory of NT$-5.48 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Lumosa Therapeutics Co and its competitors.
Is Lumosa Therapeutics Co's Change In Inventory too high?
Lumosa Therapeutics Co's current Change In Inventory is NT$-5.48 Mil. Overall, Lumosa Therapeutics Co has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lumosa Therapeutics Co's Change In Inventory compare to VRTX and REGN?
Lumosa Therapeutics Co's Change In Inventory of NT$-5.48 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Lumosa Therapeutics Co and its competitors. Lumosa Therapeutics Co's current Change In Inventory is NT$-5.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumosa Therapeutics Co stock overvalued right now?
Based on GuruFocus' analysis, Lumosa Therapeutics Co (ROCO:6535) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$138.12, compared to a current price of NT$77.40 — trading 44% below its estimated fair value. The current Change In Inventory is NT$-5.48 Mil. Lumosa Therapeutics Co's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Lumosa Therapeutics Co (ROCO:6535), the current Change In Inventory is NT$-5.48 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lumosa Therapeutics Co (ROCO:6535) Overvalued in 2026?

Based on GuruFocus' analysis, Lumosa Therapeutics Co stock appears to be undervalued. The current stock price of NT$77.40 is trading 44% below its estimated GF Value™ of NT$138.12. GuruFocus considers Lumosa Therapeutics Co to be Significantly Undervalued.

Key valuation signals for ROCO:6535:

  • Change In Inventory: NT$-5.48 Mil
  • GF Value™: NT$138.12 vs. price of NT$77.40 (44% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6535 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lumosa Therapeutics Co Business Description

Address Park Street, 4th Floor, No. 3-2, Nangang District, Taipei, TWN, 11503
Lumosa Therapeutics Co Ltd develops new drugs. The company is engaged in the development of drugs for unmet medical needs in the fields of oncology and Neuroscience. Geographically, it derives a majority of its revenue from Taiwan and also has a presence in Asia, and America. The product pipeline of the company is Neuroscience, which includes LT 1001 for Postoperative Pain, LT 3001 for Acute Ischemic Stroke, LT 5001 for Uremic Pruritus, LT 6001 for Neurological disorder, and Oncology, including LT 2003 for Solid Tumor. It generates revenue from sales of goods.
65GF Score

Get the complete analysis for ROCO:6535

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$77.40
Price
NT$138.12
GF Value